News ViiV's HIV drug could be used for TB co-infection patients Interim results suggest new treatment option for patients with TB and HIV
News ViiV to begin trials of HIV prevention injection GSK hopes patients will prefer PrEP injection to pills.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
